# A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate

> **NCT05160363** · PHASE1 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 37 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pyronaridine Tetraphosphate
- **DRUG:** Piperaquine tetraphosphate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05160363
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-14
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-05-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05160363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05160363, "A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05160363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*